How I treat chronic myeloid leukemia in the imatinib era von Goldman, John M.

Volltext

Chronic Myeloid Leukemia: A Historical Perspective von Goldman, John M

Volltext

Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibito... von MARIN, David, IBRAHIM, Amr R, PAVLU, Jiri, PALIOMPEIS, Christos, REID, Alistair, REZVANI, Katayoun, GOLDMAN, John M, FORONI, Letizia, LUCAS, Claire, GERRARD, Gareth, LIHUI WANG, SZYDLO, Richard M, CLARK, Richard E, APPERLEY, Jane F, MILOJKOVIC, Dragana, BUA, Marco

Volltext

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interf... von Hughes, Timothy P., Hochhaus, Andreas, Branford, Susan, Müller, Martin C., Kaeda, Jaspal S., Foroni, Letizia, Druker, Brian J., Guilhot, François, Larson, Richard A., O'Brien, Stephen G., Rudoltz, Marc S., Mone, Manisha, Wehrle, Elisabeth, Modur, Vijay, Goldman, John M., Radich, Jerald P.

Volltext

Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis von DE LAVALLADE, Hugues, APPERLEY, Jane F, MARIN, David, KHORASHAD, Jamshid S, MILOJKOVIC, Dragana, REID, Alistair G, BUA, Marco, SZYDLO, Richard, OLAVARRIA, Eduardo, KAEDA, Jaspal, GOLDMAN, John M

Volltext

Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias von Walker, Christopher J., Oaks, Joshua J., Santhanam, Ramasamy, Neviani, Paolo, Harb, Jason G., Ferenchak, Gregory, Ellis, Justin J., Landesman, Yosef, Eisfeld, Ann-Kathrin, Gabrail, Nash Y., Smith, Carrie L., Caligiuri, Michael A., Hokland, Peter, Roy, Denis Claude, Reid, Alistair, Milojkovic, Dragana, Goldman, John M., Apperley, Jane, Garzon, Ramiro, Marcucci, Guido, Shacham, Sharon, Kauffman, Michael G., Perrotti, Danilo

Volltext

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison o... von Branford, Susan, Fletcher, Linda, Cross, Nicholas C.P., Müller, Martin C., Hochhaus, Andreas, Kim, Dong-Wook, Radich, Jerald P., Saglio, Giuseppe, Pane, Fabrizio, Kamel-Reid, Suzanne, Wang, Y. Lynn, Press, Richard D., Lynch, Kevin, Rudzki, Zbigniew, Goldman, John M., Hughes, Timothy

Volltext

Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies von Oaks, Joshua J., Santhanam, Ramasamy, Walker, Christopher J., Roof, Steve, Harb, Jason G., Ferenchak, Greg, Eisfeld, Ann-Kathrin, Van Brocklyn, James R., Briesewitz, Roger, Saddoughi, Sahar A., Nagata, Kyosuke, Bittman, Robert, Caligiuri, Michael A., Abdel-Wahab, Omar, Levine, Ross, Arlinghaus, Ralph B., Quintas-Cardama, Alfonso, Goldman, John M., Apperley, Jane, Reid, Alistair, Milojkovic, Dragana, Ziolo, Mark T., Marcucci, Guido, Ogretmen, Besim, Neviani, Paolo, Perrotti, Danilo

Volltext

Relapse and Late Mortality in 5-Year Survivors of Myeloablative Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia in First Chronic Phase von Goldman, John M, Majhail, Navneet S, Klein, John P, Wang, Zhiwei, Sobocinski, Kathleen A, Arora, Mukta, Horowitz, Mary M, Rizzo, J Douglas

Volltext

Finding of Kinase Domain Mutations in Patients With Chronic Phase Chronic Myeloid Leukemia Responding to Imatinib May Identify Those at High Risk of Disease Progression von KHORASHAD, Jamshid S, DE LAVALLADE, Hugues, MARIN, David, APPERLEY, Jane F, MILOJKOVIC, Dragana, REID, Alistair G, BUA, Marco, SZYDLO, Richard, OLAVARRIA, Eduardo, KAEDA, Jaspal, GOLDMAN, John M

Volltext

European Treatment and Outcome Study (EUTOS) score for chronic myeloid leukemia still requires more confirmation von Marin, David, Ibrahim, Amr R, Goldman, John M

Volltext

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models von Mahon, François-Xavier, Belloc, Francis, Lagarde, Valérie, Chollet, Claudine, Moreau-Gaudry, François, Reiffers, Josy, Goldman, John M., Melo, Junia V.

Volltext

Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia von MILOJKOVIC, Dragana, NICHOLSON, Emma, KHORASHAD, Jamshid S, DE LAVALLADE, Hugues, REZVANI, Katy, PALIOMPEIS, Christos, GOLDMAN, John M, MARIN, David, APPERLEY, Jane F, HOLYOAKE, Tessa L, SHEPHERD, Pat, DRUMMOND, Mark W, SZYDIO, Richard, BUA, Marco, FORONI, Letizia, REID, Alistair

Volltext

Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia von BARNES, David J, PALAIOLOGOU, Danai, PANOUSOPOULOU, Eleni, SCHULTHEIS, Beate, YONG, Agnes S. M, WONG, Alice, PATTACINI, Laura, GOLDMAN, John M, MELO, Junia V

Volltext

Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia von Olavarria, Eduardo, Siddique, Shamyla, Griffiths, Michael J., Avery, Sharon, Byrne, Jenny L., Piper, Karen P., Lennard, Anne L., Pallan, Lalit, Arrazi, Julie M., Perz, Jolanta B., O'Shea, Derville, Goldman, John M., Apperley, Jane F., Craddock, Charles F.

Volltext

Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase von Pavlů, Jiří, Kew, Andrea K., Taylor-Roberts, Beatrice, Auner, Holger W., Marin, David, Olavarria, Eduardo, Kanfer, Edward J., MacDonald, Donald H., Milojkovic, Dragana, Rahemtulla, Amin, Rezvani, Katayoun, Goldman, John M., Apperley, Jane F., Szydlo, Richard M.

Volltext

Ponatinib for Chronic Myeloid Leukemia von Goldman, John M

Volltext

What challenges remain in chronic myeloid leukemia research? von Carella, Angelo M, Branford, Susan, Deininger, Michael, Mahon, Francois X, Saglio, Giuseppe, Eiring, Anna, Khorashad, Jamshid, O'Hare, Thomas, Goldman, John M

Volltext

Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? von Querol, Sergio, Mufti, Ghulam J, Marsh, Steven G.E, Pagliuca, Antonio, Little, Ann-Margaret, Shaw, Bronwen E, Jeffery, Robert, Garcia, Joan, Goldman, John M, Madrigal, J. Alejandro

Volltext

Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib von Marin, David, Hedgley, Corinne, Clark, Richard E., Apperley, Jane, Foroni, Letizia, Milojkovic, Dragana, Pocock, Christopher, Goldman, John M., O'Brien, Stephen

Volltext